Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Blood neurofilament light as a potential endpoint in Phase 2 studies in MS.

Sormani MP, Haering DA, Kropshofer H, Leppert D, Kundu U, Barro C, Kappos L, Tomic D, Kuhle J.

Ann Clin Transl Neurol. 2019 May 28;6(6):1081-1089. doi: 10.1002/acn3.795. eCollection 2019 Jun.

2.

Electronic Neurostatus-EDSS increases the quality of expanded disability status scale assessments: Experience from two phase 3 clinical trials.

D'Souza M, Heikkilä A, Lorscheider J, Haller V, Kravalis K, Gysin S, Fuertes NAC, Fricker E, Lam E, Higgins P, Tomic D, Papadopoulou A, Kappos L.

Mult Scler. 2019 May 7:1352458519845108. doi: 10.1177/1352458519845108. [Epub ahead of print]

PMID:
31060429
3.
4.

Pelvis Anatomy Tutorial Using Radiological Images.

Marsland MJ, Tomic D, Brian PL, Lazarus MD.

MedEdPORTAL. 2018 Nov 28;14:10778. doi: 10.15766/mep_2374-8265.10778.

5.

Abdominal Anatomy Tutorial Using a Medical Imaging Platform.

Marsland MJ, Tomic D, Brian PL, Lazarus MD.

MedEdPORTAL. 2018 Aug 30;14:10748. doi: 10.15766/mep_2374-8265.10748.

6.

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response.

Kuhle J, Kropshofer H, Haering DA, Kundu U, Meinert R, Barro C, Dahlke F, Tomic D, Leppert D, Kappos L.

Neurology. 2019 Mar 5;92(10):e1007-e1015. doi: 10.1212/WNL.0000000000007032. Epub 2019 Feb 8.

7.

Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis.

Chitnis T, Gonzalez C, Healy BC, Saxena S, Rosso M, Barro C, Michalak Z, Paul A, Kivisakk P, Diaz-Cruz C, Sattarnezhad N, Pierre IV, Glanz BI, Tomic D, Kropshofer H, Häring D, Leppert D, Kappos L, Bakshi R, Weiner HL, Kuhle J.

Ann Clin Transl Neurol. 2018 Oct 16;5(12):1478-1491. doi: 10.1002/acn3.638. eCollection 2018 Dec.

8.

Learning ability correlates with brain atrophy and disability progression in RRMS.

Sormani MP, De Stefano N, Giovannoni G, Langdon D, Piani-Meier D, Haering DA, Kappos L, Tomic D.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):38-43. doi: 10.1136/jnnp-2018-319129. Epub 2018 Oct 15.

9.

Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies.

Tomic D, Kemp WW, Roberts SK.

Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1103-1115. doi: 10.1097/MEG.0000000000001235. Review.

PMID:
30113367
10.

Clinical Correlations of Brain Lesion Location in Multiple Sclerosis: Voxel-Based Analysis of a Large Clinical Trial Dataset.

Altermatt A, Gaetano L, Magon S, Häring DA, Tomic D, Wuerfel J, Radue EW, Kappos L, Sprenger T.

Brain Topogr. 2018 Sep;31(5):886-894. doi: 10.1007/s10548-018-0652-9. Epub 2018 May 29.

PMID:
29845492
11.

Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.

Gaetano L, Häring DA, Radue EW, Mueller-Lenke N, Thakur A, Tomic D, Kappos L, Sprenger T.

Neurology. 2018 Apr 10;90(15):e1324-e1332. doi: 10.1212/WNL.0000000000005292. Epub 2018 Mar 14.

PMID:
29540589
12.

Cost Analysis of the Addition of Hyperacute Magnetic Resonance Imaging for Selection of Patients for Endovascular Stroke Therapy.

John S, Thompson NR, Lesko T, Papesh N, Obuchowski N, Tomic D, Wisco D, Khawaja Z, Uchino K, Man S, Cheng-Ching E, Toth G, Masaryk T, Ruggieri P, Modic M, Hussain MS.

Interv Neurol. 2017 Oct;6(3-4):183-190. doi: 10.1159/000472158. Epub 2017 May 5.

13.

Dysphagia: Thinking outside the box.

Philpott H, Garg M, Tomic D, Balasubramanian S, Sweis R.

World J Gastroenterol. 2017 Oct 14;23(38):6942-6951. doi: 10.3748/wjg.v23.i38.6942. Review.

14.

α4-integrin receptor desaturation and disease activity return after natalizumab cessation.

Derfuss T, Kovarik JM, Kappos L, Savelieva M, Chhabra R, Thakur A, Zhang Y, Wiendl H, Tomic D.

Neurol Neuroimmunol Neuroinflamm. 2017 Aug 25;4(5):e388. doi: 10.1212/NXI.0000000000000388. eCollection 2017 Sep.

15.

"No evident disease activity": The use of combined assessments in the management of patients with multiple sclerosis.

Giovannoni G, Tomic D, Bright JR, Havrdová E.

Mult Scler. 2017 Aug;23(9):1179-1187. doi: 10.1177/1352458517703193. Epub 2017 Apr 6. Review.

16.

Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses.

Giovannoni G, Cutter G, Sormani MP, Belachew S, Hyde R, Koendgen H, Knappertz V, Tomic D, Leppert D, Herndon R, Wheeler-Kingshott CAM, Ciccarelli O, Selwood D, di Cantogno EV, Ben-Amor AF, Matthews P, Carassiti D, Baker D, Schmierer K.

Mult Scler Relat Disord. 2017 Feb;12:70-78. doi: 10.1016/j.msard.2017.01.007. Epub 2017 Jan 17. Review.

PMID:
28283111
17.

Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.

Merschhemke M, Tomic D, Putzki N.

JAMA Neurol. 2016 Nov 1;73(11):1375. doi: 10.1001/jamaneurol.2016.3199. No abstract available.

PMID:
27669336
18.

"It's Always the Judge's Fault": Attention, Emotion Recognition, and Expertise in Rhythmic Gymnastics Assessment.

van Bokhorst LG, Knapová L, Majoranc K, Szebeni ZK, Táborský A, Tomić D, Cañadas E.

Front Psychol. 2016 Jul 5;7:1008. doi: 10.3389/fpsyg.2016.01008. eCollection 2016.

19.

Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.

Sormani MP, Kappos L, Radue EW, Cohen J, Barkhof F, Sprenger T, Piani Meier D, Häring D, Tomic D, De Stefano N.

Mult Scler. 2017 Apr;23(5):656-664. doi: 10.1177/1352458516659550. Epub 2016 Jul 18.

PMID:
27411701
20.

Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients.

De Stefano N, Tomic D, Radue EW, Sprenger T, Meier DP, Häring D, Sormani MP.

Mult Scler Relat Disord. 2016 May;7:98-101. doi: 10.1016/j.msard.2016.03.017. Epub 2016 Mar 31.

PMID:
27237768
21.

Automated brain volumetrics in multiple sclerosis: a step closer to clinical application.

Wang C, Beadnall HN, Hatton SN, Bader G, Tomic D, Silva DG, Barnett MH.

J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):754-7. doi: 10.1136/jnnp-2015-312304. Epub 2016 Apr 12.

22.

Comparison of high glucose concentration blood and crystalloid cardioplegia in paediatric cardiac surgery: a randomized clinical trial.

Mimic B, Ilic S, Vulicevic I, Milovanovic V, Tomic D, Mimic A, Stankovic S, Zecevic T, Davies B, Djordjevic M.

Interact Cardiovasc Thorac Surg. 2016 May;22(5):553-60. doi: 10.1093/icvts/ivv391. Epub 2016 Jan 31.

23.

Optimizing treatment success in multiple sclerosis.

Ziemssen T, Derfuss T, de Stefano N, Giovannoni G, Palavra F, Tomic D, Vollmer T, Schippling S.

J Neurol. 2016 Jun;263(6):1053-65. doi: 10.1007/s00415-015-7986-y. Epub 2015 Dec 24. Review.

24.

Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.

Kappos L, Radue EW, Chin P, Ritter S, Tomic D, Lublin F.

J Neurol. 2016 Feb;263(2):354-360. doi: 10.1007/s00415-015-7978-y. Epub 2015 Dec 8.

25.

Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis.

Kappos L, De Stefano N, Freedman MS, Cree BA, Radue EW, Sprenger T, Sormani MP, Smith T, Häring DA, Piani Meier D, Tomic D.

Mult Scler. 2016 Sep;22(10):1297-305. doi: 10.1177/1352458515616701. Epub 2015 Nov 19.

26.

Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis.

Derfuss T, Bergvall NK, Sfikas N, Tomic DL.

Curr Med Res Opin. 2015;31(9):1687-91. doi: 10.1185/03007995.2015.1067191. Epub 2015 Aug 20.

PMID:
26121423
27.

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.

Cohen JA, Khatri B, Barkhof F, Comi G, Hartung HP, Montalban X, Pelletier J, Stites T, Ritter S, von Rosenstiel P, Tomic D, Kappos L; TRANSFORMS (TRial Assessing injectable interferoN vS. FTY720 Oral in RRMS) Study Group.

J Neurol Neurosurg Psychiatry. 2016 May;87(5):468-75. doi: 10.1136/jnnp-2015-310597. Epub 2015 Jun 25.

28.

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.

Kappos L, Radue EW, Comi G, Montalban X, Butzkueven H, Wiendl H, Giovannoni G, Hartung HP, Derfuss T, Naegelin Y, Sprenger T, Mueller-Lenke N, Griffiths S, von Rosenstiel P, Gottschalk R, Zhang Y, Dahlke F, Tomic D; TOFINGO study group.

Neurology. 2015 Jul 7;85(1):29-39. doi: 10.1212/WNL.0000000000001706. Epub 2015 May 29.

29.

No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis.

Nixon R, Bergvall N, Tomic D, Sfikas N, Cutter G, Giovannoni G.

Adv Ther. 2014 Nov;31(11):1134-54. doi: 10.1007/s12325-014-0167-z. Epub 2014 Nov 21.

30.

Nutrition labelling of pre-packaged foods in Belgrade, Serbia: current situation.

Davidović DB, Tomić DV, Paunović KŽ, Vasiljević ND, Jorga JB.

Public Health Nutr. 2015 Aug;18(11):1969-78. doi: 10.1017/S1368980014002353. Epub 2014 Nov 6.

PMID:
25374093
31.

Relapses in patients treated with fingolimod after previous exposure to natalizumab.

Comi G, Gold R, Dahlke F, Sinha A, von Rosenstiel P, Tomic D, Kappos L.

Mult Scler. 2015 May;21(6):786-90. doi: 10.1177/1352458514549404. Epub 2014 Sep 25.

PMID:
25257618
32.

Lorenz Heister's handbook of surgery in the Franciscan monastery in Pazin.

Tomić D, Laginja S.

Med Glas (Zenica). 2014 Feb;11(1):228-33.

PMID:
24496369
33.

European validation of a real-time PCR-based method for detection of Listeria monocytogenes in soft cheese.

Gianfranceschi MV, Rodriguez-Lazaro D, Hernandez M, González-García P, Comin D, Gattuso A, Delibato E, Sonnessa M, Pasquali F, Prencipe V, Sreter-Lancz Z, Saiz-Abajo MJ, Pérez-De-Juan J, Butrón J, Kozačinski L, Tomic DH, Zdolec N, Johannessen GS, Jakočiūnė D, Olsen JE, De Santis P, Lovari S, Bertasi B, Pavoni E, Paiusco A, De Cesare A, Manfreda G, De Medici D.

Int J Food Microbiol. 2014 Aug 1;184:128-33. doi: 10.1016/j.ijfoodmicro.2013.12.021. Epub 2013 Dec 28.

PMID:
24468028
34.

[Can decubitus ulcer be fatal? - case report].

Tomić D, Laginja S.

Acta Med Croatica. 2013 Oct;67 Suppl 1:107-9. Croatian.

PMID:
24371984
35.

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.

Gold R, Comi G, Palace J, Siever A, Gottschalk R, Bijarnia M, von Rosenstiel P, Tomic D, Kappos L; FIRST Study Investigators.

J Neurol. 2014 Feb;261(2):267-76. doi: 10.1007/s00415-013-7115-8. Epub 2013 Nov 13.

36.

Endoscopic ultrasound for differential diagnosis of duodenal lesions.

Pavlovic Markovic A, Rösch T, Alempijevic T, Krstic M, Tomic D, Dugalic P, Sokic Milutinovic A, Bulajic M.

Ultraschall Med. 2012 Dec;33(7):E210-E217. doi: 10.1055/s-0032-1313135. Epub 2012 Nov 5.

PMID:
23129520
37.

Assessment of metabolic syndrome in patients with primary biliary cirrhosis.

Alempijevic T, Sokic-Milutinovic A, Pavlovic Markovic A, Jesic-Vukicevic R, Milicic B, Macut D, Popovic D, Tomic D.

Wien Klin Wochenschr. 2012 Apr;124(7-8):251-5. doi: 10.1007/s00508-012-0162-9. Epub 2012 Apr 25.

PMID:
22531844
38.

Frequency and clinical caracteristics of colorectal adenoma and carcinoma in women.

Alempijević T, Milutinović AS, Marković AP, Krstić R, Popović D, Djuranović S, Spuran M, Tomić D, Ugljesić M.

Acta Chir Iugosl. 2011;58(4):51-4.

PMID:
22519192
39.

Dietary habits as a risk factor of gallstone disease in Serbia.

Davidović DB, Tomić DV, Jorg JB.

Acta Chir Iugosl. 2011;58(4):41-4.

PMID:
22519190
40.

Ultrasound diagnosis of gallbladder polyps.

Tomić DV, Marković AR, Alempijević TM, Davidović DB, Prsić DR, Vucković MS.

Acta Chir Iugosl. 2011;58(4):31-5.

PMID:
22519188
41.

An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers.

Brooks DJ, Papapetropoulos S, Vandenhende F, Tomic D, He P, Coppell A, O'Neill G.

Clin Neuropharmacol. 2010 Mar-Apr;33(2):55-60. doi: 10.1097/WNF.0b013e3181d137d2.

PMID:
20375654
42.

Acquisition of /s/ clusters in Croatian speaking children with phonological disorders.

Mildner V, Tomić D.

Clin Linguist Phon. 2010 Jan;24(3):224-38. doi: 10.3109/02699200903362893.

PMID:
20144082
43.

Photobleaching for optical waveguide formation in a guest-host polyimide.

Tomić D, Mickelson A.

Appl Opt. 1999 Jun 20;38(18):3893-903.

PMID:
18319996
44.

[Ultrasonographic aspects of liver segmentation].

Alempijević T, Kovacević N, Stimec B, Tomić D.

Med Pregl. 2007 Sep-Oct;60(9-10):501-4. Review. Serbian.

PMID:
18265601
45.

Gastric multicentric glomangioma: a case report of this rare cause of abdominal pain.

Alempijevic T, Knezevic S, Knezevic D, Ostojic S, Stojakov D, Micev M, Tomic D, Krstic M.

Med Sci Monit. 2008 Jan;14(1):CS5-8.

PMID:
18160947
46.

Right liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertension.

Alempijevic T, Bulat V, Djuranovic S, Kovacevic N, Jesic R, Tomic D, Krstic S, Krstic M.

World J Gastroenterol. 2007 Oct 28;13(40):5331-5.

47.

[Fever of unknown origin--a case report of brucellar discitis].

Tomić D, Stokić E, Turkulov V, Ivković-Lazar T.

Med Pregl. 2007 Jan-Feb;60(1-2):77-9. Serbian.

PMID:
17853716
48.

[Noninvasive assessment of oesophageal varices presence and size in patients with liver cirrhosis using right liver lobe/serum albumin concentration].

Alempijević T, Bulat V, Kovacević N, Jegić R, Duranović S, Tomić D, Krstić M.

Vojnosanit Pregl. 2007 Jul;64(7):453-7. Serbian.

PMID:
17821919
49.

Double common bile duct: a case report.

Djuranovic SP, Ugljesic MB, Mijalkovic NS, Korneti VA, Kovacevic NV, Alempijevic TM, Radulovic SV, Tomic DV, Spuran MM.

World J Gastroenterol. 2007 Jul 21;13(27):3770-2.

50.

Snodgrass' urethroplasty in hypospadias surgery in Clinical Hospital Mostar--preliminary report.

Brekalo Z, Kvesić A, Nikolić H, Tomić D, Martinović V.

Coll Antropol. 2007 Mar;31(1):189-93.

PMID:
17598400

Supplemental Content

Support Center